Mia's Feed
Medical News & Research

Innovative Microfluidic Device Achieves 90% Efficiency in Detecting Cancer Cells in Blood

Innovative Microfluidic Device Achieves 90% Efficiency in Detecting Cancer Cells in Blood

Share this article

A new microfluidic device developed by Japanese scientists can detect circulating tumor cells in blood with over 90% efficiency, paving the way for early and minimally invasive cancer diagnosis.

2 min read

Recent advancements in microfluidic technology have enabled the development of highly sensitive diagnostic tools for cancer detection. Researchers from Chiba University in Japan have engineered a novel microdevice that can capture circulating tumor cells (CTCs) from blood with over 90% efficiency, even at high flow rates. This device utilizes microcones, fabricated on polycarbonate sheets via thermal nanoimprint lithography, which are coated with antibodies targeting specific cancer cell markers.

The microcones, approximately 30 micrometers in size and arranged in a hexagonal pattern, enhance the capture of CTCs by exploiting surface chemistry and morphology. By controlling the orientation angles of these microcones, the team optimized the device’s performance, achieving consistent capture rates for breast and lung cancer cells. Notably, when the microcones were angled at 15° or 30°, the capture efficiency remained above 90%, highlighting the importance of microstructure arrangement.

The device's microchannels enable the flow of blood samples, with captured cancer cells remaining immobilized within the channels. Fluorescent dye staining confirmed the successful trapping and identification of cancer cells, which could be distinguished easily under fluorescent light. This approach offers a minimally invasive, cost-effective alternative to traditional cancer detection methods.

Professor Masumi Yamada and his team envision that this microfluidic system can be used not only for early cancer diagnosis but also for monitoring treatment efficacy and disease recurrence. By enabling reliable detection of CTCs from simple blood tests, this technology holds promise for improving cancer management and patient outcomes.

This cutting-edge research was published in the journal Lab on a Chip on May 28, 2025, and demonstrates a significant step forward in microfluidic-based cancer diagnostics.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Promising Early-Stage HIV Vaccine Shows Targeted Immune Response in Human Trial

Amsterdam researchers have developed an innovative HIV vaccine that successfully triggers targeted immune responses in early trials, marking a significant step toward an effective global HIV vaccine.

How 'Weird Shading' Illusions Help Explain 3D Perception in the Brain

New research reveals that the brain interprets shading through line patterns, rather than complex physics, explaining how we perceive 3D shapes from simple images and artistic techniques.

Massive Staffing Reductions at U.S. Federal Health Agencies Following Supreme Court Ruling

Thousands of employees at NIH, FDA, and CDC are facing layoffs following a Supreme Court decision, raising concerns over the impact on public health services and agency operations.